ব্রাজিল - পর্তুগীজ - ANVISA (Agência Nacional de Vigilância Sanitária)

organon farmacÊutica ltda. - supressores da reabsorcao ossea

ব্রাজিল - পর্তুগীজ - ANVISA (Agência Nacional de Vigilância Sanitária)

organon farmacÊutica ltda. - antiglaucomatosos

ব্রাজিল - পর্তুগীজ - ANVISA (Agência Nacional de Vigilância Sanitária)

organon farmacÊutica ltda. - antiglaucomatosos

ব্রাজিল - পর্তুগীজ - ANVISA (Agência Nacional de Vigilância Sanitária)

organon farmacÊutica ltda. - antilipemicos

ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

astrazeneca ab - andexanet alfa - relacionados com drogas, efeitos colaterais e reações adversas - todos os outros produtos terapêuticos - para pacientes adultos tratados com uma diretos do fator xa (fxa) inibidor (apixaban ou o rivaroxaban) quando reversão da anticoagulação é necessária devido ao risco de vida ou sangramento descontrolado.

ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocitopenia - anti-hemorrágicos - doptelet é indicado para o tratamento da trombocitopenia grave em doentes adultos com doença crônica do fígado, que são programados para se submeter a um procedimento invasivo. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. corticosteróides, imunoglobulinas).

ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

astrazeneca ab - acalabrutinib - leucemia, linfocítica, crônica, células b - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

astrazeneca ab - moxetumomab pasudotox - leucemia, células peludas - agentes antineoplásicos - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).

ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - agentes antineoplásicos - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.

ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinúria, paroxística - imunossupressores - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.